コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 itory areas represent acoustic space remains a matter of debate.
2 d progression to homologous pairing is still a matter of debate.
3 ed side-effects, on the other hand, is still a matter of debate.
4 thin the so-called magnetosomes has remained a matter of debate.
5 expected anoxic and reducing conditions are a matter of debate.
6 tion acute coronary syndromes (NSTE-ACSs) is a matter of debate.
7 immunotherapy in polysensitized subjects is a matter of debate.
8 through a molecular mechanism that is still a matter of debate.
9 f OX1R and OX2R for sleep induction is still a matter of debate.
10 which in the case of retaining GTs is still a matter of debate.
11 ates and molecular structures of MscL remain a matter of debate.
12 c stimuli (e.g., simple tones) and are still a matter of debate.
13 reactive inflammatory or neoplastic has been a matter of debate.
14 and the onset of neurodegeneration is still a matter of debate.
15 sthesia-induced loss of consciousness remain a matter of debate.
16 rect interactions with the substrate remains a matter of debate.
17 quester carbon to mitigate climate change is a matter of debate.
18 r physiological basis is in many cases still a matter of debate.
19 as opposed to transcriptional noise, remains a matter of debate.
20 s, yet their functions and mechanisms remain a matter of debate.
21 AR will have systemic atopy in the future is a matter of debate.
22 its relevance for synaptic function is still a matter of debate.
23 p in patients in a vegetative state is still a matter of debate.
24 in the early 1960s, their structure has been a matter of debate.
25 ributions to episodic future thinking remain a matter of debate.
26 ady state, their role during inflammation is a matter of debate.
27 nt at which cART should be initiated remains a matter of debate.
28 ogap phase and quantum criticality are still a matter of debate.
29 and spirituality in psychiatry continues as a matter of debate.
30 y and its role in memory impairment is still a matter of debate.
31 hough the optimal screening strategy remains a matter of debate.
32 d, the role of p73 in tumorigenesis is still a matter of debate.
33 munosuppressed patients without PML has been a matter of debate.
34 ate from neural and epidermal fates has been a matter of debate.
35 s a role in inhibiting CO formation has been a matter of debate.
36 essive-compulsive-related disorders is still a matter of debate.
37 adjuvant irradiation to nodal basins is also a matter of debate.
38 ed to RPE65, its catalytic mechanism remains a matter of debate.
39 elates of this process in organisms is still a matter of debate.
40 ing cellular and molecular mechanisms remain a matter of debate.
41 source of the currents which produce them is a matter of debate.
42 n and Isu is mediated by adaptor proteins is a matter of debate.
43 excitatory postsynaptic potentials (EPSP) is a matter of debate.
44 red, the significance of this effect remains a matter of debate.
45 r the processing of auditory motion is still a matter of debate.
46 tives within fibrillar melanosomes have been a matter of debate.
47 erior cingulate cortex (ACC) in attention is a matter of debate.
48 race their ancestry to the first settlers is a matter of debate.
49 he linker histone on the nucleosome is still a matter of debate.
50 with metastatic thyroid cancer (TC) is still a matter of debate.
51 ir mechanisms of biological action are still a matter of debate.
52 lished, mechanisms of UVA mutagenesis remain a matter of debate.
53 ment of protein(s) to this function is still a matter of debate.
54 otential of hydroxyurea (HU) continues to be a matter of debate.
55 nism underlying voltage sensing has remained a matter of debate.
56 t biochemical parameters and is increasingly a matter of debate.
57 art of the normal response to injury remains a matter of debate.
58 lationship to cognitive impairment are still a matter of debate.
59 eatment of gastric carcinoid tumors is still a matter of debate.
60 of the adult nervous system continues to be a matter of debate.
61 ystem or in dopamine receptors still remains a matter of debate.
62 ry effects of melanocortin peptides is still a matter of debate.
63 es, particularly those more remote, is still a matter of debate.
64 role in accelerating folding rates, remains a matter of debate.
65 iology and its mechanism of action are still a matter of debate.
66 the frontal cortex in consciousness remains a matter of debate.
67 mpared with less extensive surgery, has been a matter of debate.
68 around a pre-existing template is currently a matter of debate.
69 ned after infection or vaccination are still a matter of debate.
70 uired in the activation of cysteine has been a matter of debate.
71 ells occur in anatomically distinct sites is a matter of debate.
72 e significance of this intermediate has been a matter of debate.
73 vidual peptide to positive selection remains a matter of debate.
74 echanisms as visual perception has long been a matter of debate.
75 g reproduction-longevity associations remain a matter of debate.
76 loit chromatic information, however, remains a matter of debate.
77 itor (stem) cells in the human liver remains a matter of debate.
78 ming of operation in elective cases has been a matter of debate.
79 y evolving land plant lineages has long been a matter of debate.
80 trast-induced acute kidney injury (CIAKI) is a matter of debate.
81 tive compound whose biological role is still a matter of debate.
82 cteria and these metabolic disorders remains a matter of debate.
83 he impact of TREM2 on Abeta accumulation are a matter of debate.
84 ess, how the MCM translocates on DNA remains a matter of debate.
85 inding specificity of the CPEB2 subfamily is a matter of debate.
86 d chemoradiotherapy for primary treatment is a matter of debate.
87 asis of this functional interaction is still a matter of debate.
88 of bona fide RNA G4s in cells has long been a matter of debate.
89 overexpression of nigral alpha-syn are still a matter of debate.
90 with diffuse large B-cell lymphomas is still a matter of debate.
91 on of chloroplast Toc75 POTRA domains remain a matter of debate.
92 nd distribution of dominant lineages remains a matter of debate.
93 rain handles spatiotopic information remains a matter of debate.
94 AP meet MHC-I molecules for loading has been a matter of debate.
95 nabinoid receptor in the brain has long been a matter of debate.
96 as an early xylem-delivered signal is still a matter of debate.
97 el during motility and host cell invasion is a matter of debate.
98 glia response in Alzheimer's disease remains a matter of debate.
99 The neural basis of amblyopia is a matter of debate.
100 during electrospray ionization (ESI) remains a matter of debate.
101 ansitions in human skeletal muscle are still a matter of debate.
102 actions, their underlying motivations remain a matter of debate.
103 nce in kidney transplant recipients still is a matter of debate.
104 ty--involves analogous processing streams is a matter of debate.
105 ffecting 3% of the human population, remains a matter of debate.
106 e of the constricted conformation has become a matter of debate.
107 al limit of the lateral resolution are still a matter of debate.
108 drugs based on specific biomarkers) is still a matter of debate.
109 al after liver transplantation (LT) is still a matter of debate.
110 vements in the therapeutic approach is still a matter of debate.
111 neck dissection after nodal relapse has been a matter of debate.
112 reening, and the timing of such effects, are a matter of debate.
113 astrointestinal tuberculosis continues to be a matter of debate.
114 also spreads by cell-cell contact in vivo is a matter of debate.
115 cardiovascular disease (CVD) risk are still a matter of debate.
116 lls on the uptake of the radiotracer remains a matter of debate.
117 the RANKL-RANK axis on B physiology is still a matter of debate.
118 y is initially broken, however, has remained a matter of debate.
119 ifferent FEM types influence this process is a matter of debate.
120 owth inhibition and bacterial persistence is a matter of debate.
121 tive importance of these two factors remains a matter of debate.
122 partment of myeloma progenitor cells remains a matter of debate.
123 nate at a motor or attentional level remains a matter of debate.
124 ies, but their causative connection is still a matter of debate.
125 but the central theme of the differences is a matter of debate.
126 2 receptor or a separate entity is currently a matter of debate.
127 ay the ribosome contributes to catalysis are a matter of debate.
128 as been of great interest, yet still remains a matter of debate.
129 e after liver transplantation (LT) are still a matter of debate.
130 y which Abeta amyloid forms in vivo has been a matter of debate.
131 s of this attentional gain control are still a matter of debate.
132 s associated with these properties are still a matter of debate.
133 bilateral adrenal hyperplasia (BAH), remains a matter of debate.
134 mpassing theories, and their origin is still a matter of debate.
135 ut bilirubin <4 mg/dL and no cholangitis) is a matter of debate.
136 tosis from colorectal cancer (CRPC) is still a matter of debate.
137 worldwide, its benefit-to-risk ratio remains a matter of debate.
138 cesses, their relative contribution is still a matter of debate.
139 sses, the in vivo role of beta1 integrins is a matter of debate.
140 experimental and clinical settings is still a matter of debate.
141 large-scale cortical network dynamics remain a matter of debate.
142 rrier function to allergic diseases is still a matter of debate.
143 the responses of a population of neurons are a matter of debate.
144 vacuolar anthocyanin transport has long been a matter of debate.
145 surgical coronary revascularization is still a matter of debate.
146 d activates the MIF receptor (CD74) is still a matter of debate.
147 sported as CoA esters or free acids has been a matter of debate.
150 otropy to clinical outcomes, however, remain a matter of debate and are hard to quantify because the
151 GFR pathway inhibition in this phenomenon is a matter of debate and molecular mechanisms leading to T
152 housekeeping gene in tumorigenesis is still a matter of debate and pseudo-hypoxia has been suggested
153 sis for the deleterious effect of L1 remains a matter of debate and three possible mechanisms have be
154 nthesis in stomatal conductance responses is a matter of debate, and genetic approaches are needed.
155 ether or not it has been lost from Earth, is a matter of debate, and has implications for determining
156 om the Late Glacial into the Holocene remain a matter of debate, and information on how these changes
157 erms are poorly defined, their assessment is a matter of debate, and their clinical significance is n
160 ical timing for aortic regurgitation remains a matter of debate because of limited data on its link w
161 ical nature of Casparian strips has remained a matter of debate, confounding further molecular analys
162 ants and their relative importance are still a matter of debate, especially because most regional and
165 interpreted according to visual criteria, is a matter of debate for diffuse large B-cell lymphoma (DL
166 rations of the dinucleotide, and it has been a matter of debate if polymorphism of c-di-GMP exists un
167 rties are still not fully understood and are a matter of debate in the absence of high-resolution str
169 to the hydrolysis of drug molecules, remain a matter of debate, in particular the identification of
170 other as sources of structural knowledge is a matter of debate; it is often proposed that small prot
172 or IgE responses in human subjects are still a matter of debate, largely because the immunization pro
173 The use of extended criteria has remained a matter of debate, mainly because of the absence of pro
175 ysis among enzymatic pericyclic reactions is a matter of debate, one view holding that catalysis may
176 domain containing protein 5 (NLRC5) remains a matter of debate, particularly with respect to NF-kapp
178 he optimal type of biliary drainage is still a matter of debate; recent studies have indicated that e
180 otic response across Palaeozoic seascapes is a matter of debate; several intrinsic and extrinsic driv
181 ion of 4-hydroxy-2E-nonenal (4-HNE) has been a matter of debate since it was discovered as a major cy
182 genetic basis of earlobe attachment has been a matter of debate since the early 20(th) century, such
183 The basis for this asymmetry, however, is a matter of debate; the left hemisphere may be specializ
184 of protein-coding genes it contains remains a matter of debate; the number of computational gene pre
185 ies in natural tolerance acquisition remains a matter of debate; the specific IgE/IgG(4) ratio might
188 talyze the resection of DNA ends, it remains a matter of debate whether another human RecQ helicase,
189 serves as the channel activator, it is still a matter of debate whether changes in the intracellular
192 ing the germinal center reaction, it remains a matter of debate whether the mutation machinery also t
194 ease onset without remission and it is still a matter of debate whether this disease course results f
197 function of the human appendix has long been a matter of debate, with the structure often considered
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。